DEA Form 82 Notice of Inspection: What You Are Signing

A DEA investigator who arrives at a pharmacy without a warrant presents DEA Form 82, the Notice of Inspection of Controlled Premises, and asks the pharmacist-in-charge or another person in authority to sign the consent line before the inspection begins. That signature does real legal work. Under federal regulation, signing the consent portion of Form 82 is a written waiver of the registrant's right to require a warrant before DEA inspects the premises, copies records, and counts the controlled substance stock on hand. Knowing what the form asks before anyone signs is the first decision a pharmacy faces when an investigator is at the counter.

The Form 82 Notice and What It Requires

21 C.F.R. § 1316.06 sets out what the Notice of Inspection must contain: the name and title of the owner, operator, or agent in charge of the premises, the premises name and address, the date and time of the inspection, a statement that notice is given under Section 510 of the Controlled Substances Act, and a reproduction of that section's pertinent parts on the form itself. Form 82 is the predecessor document for an inspection, not the authorization to conduct one; authority to inspect comes only from the registrant's consent or from a warrant obtained separately.

Once an inspection is underway with consent, 21 U.S.C. § 880(b) gives the investigator authority to copy required records, inspect the premises, and conduct an inventory reconciliation of the controlled substance stock. Financial data, sales data other than shipment data, and pricing data sit outside that authority unless the registrant separately consents in writing to their review.

What the Consent Signature Acknowledges

21 C.F.R. § 1316.08 governs the consent itself: a written statement signed by the owner, operator, or agent in charge, witnessed by two people, before an inspection can proceed without a warrant. The signature acknowledges that notice was properly given, that the registrant has a constitutional right not to have an administrative inspection made without a warrant, that the registrant has the right to refuse consent, and that anything incriminating found may be seized and used in a criminal prosecution. The same regulation allows the registrant to withdraw consent at any time while the inspection is underway.

Signing the consent line is a written record that the registrant understood the right to a warrant and gave it up for this inspection. Withdrawing consent mid-inspection is permitted, but it does not undo what investigators already copied, inventoried, or saw.

The Administrative Inspection Warrant Alternative

Declining to sign the consent line shifts the inspection onto a judicial track rather than ending it. 21 U.S.C. § 880(d) lets DEA apply to a United States judge, a judge of a State court of record, or a United States magistrate judge for an administrative inspection warrant, issued on a showing of a valid public interest in the effective enforcement of the Controlled Substances Act, a standard set below the probable cause required for a criminal search warrant. Declining consent is the statutory alternative Congress built into Section 880, and the time DEA needs to obtain the warrant can be used to get counsel involved before records are copied or stock is counted.

What To Do Before Signing

The records a Form 82 inspection reaches, including suspicious order monitoring records and controlled substance dispensing logs, are the same records DEA can cite later in an order to show cause or immediate suspension order proceeding against the registration itself. A pharmacist-in-charge presented with Form 82 should confirm the inspector's credentials, read the consent language rather than sign on the spot, and call counsel before agreeing to a scope beyond what Section 880 authorizes. The signature is the issue here, not whether the inspection happens at all.

Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience.

Why Early Legal Counsel Is Critical

It is critical that pharmacies and other DEA registrants promptly retain experienced healthcare defense counsel upon receiving a Form 82 notice of inspection, an administrative inspection warrant, a subpoena, or any other government inquiry. Early legal intervention can protect the registrant's rights, ensure appropriate responses to government requests, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with investigators on the registrant's behalf. Delaying legal representation can significantly affect the outcome of a matter and expose the registrant to unnecessary risk.

How Health Law Alliance Can Help

Health Law Alliance's DEA defense practice represents pharmacies and other registrants in DEA inspections, Orders to Show Cause, Immediate Suspension Orders, and other DEA proceedings that can follow a Form 82 visit. Our attorneys review the consent language and the scope of what investigators examined before advising a registrant on how to respond. If a DEA investigator has presented your pharmacy with a Notice of Inspection, contact our DEA inspections defense attorneys for a free, confidential consultation.